Beta Thalassemia

Join Sanguine's Beta Thalassemia patient community to stay informed on upcoming trials
Join Sanguine's Beta Thalassemia patient community to stay informed on upcoming trials

We Bring Research To You

Beta thalassemia is a genetic blood disorder that reduces the production of hemoglobin, which leads to a lack of oxygen in many parts of the body. These low levels of hemoglobin may cause anemia. More than 5,000 people in the U.S. are living with beta thalassemia, and better medicine and treatment options are needed for Beta Thalassemia.

We believe patients like you are the key to making a difference in Beta Thalassemia research. Joining a research study can help advance the future of Beta Thalassemia research and impact the development of new treatments and cures.

Sanguine's unique model alleviates many of the difficulties associated with clinical trials and we make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel. Sign up to learn more and participate today!

Sanguine's Expertise in Accelerating Research

25,000+
Members in
our community
3
Average # of times a
member has participated
500+
Studies completed
by Sanguine

We are currently not recruiting

Stay in touch and we will let you know when the next recruitment is available.

Nationwide Partners

We partner with these like-minded organizations and nonprofits to connect with patients who want to contribute and help accelerate research.

OUR PARTNERS INCLUDE:

Want to see more? View our full list of Nationwide Partners:

Join the Sanguine community!